Efficacy of Rituximab and Plasma Exchange in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis with Severe Kidney Disease

BACKGROUND: Treatment of patients with ANCA-associated vasculitis (AAV) and severe renal involvement is not established. We describe outcomes in response to rituximab (RTX) versus cyclophosphamide (CYC) and plasma exchange (PLEX). METHODS: A retrospective cohort study of MPO- or PR3-ANCA–positive pa...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Am Soc Nephrol
Main Authors: Casal Moura, Marta, Irazabal, Maria V., Eirin, Alfonso, Zand, Ladan, Sethi, Sanjeev, Borah, Bijan J., Winters, Jeffrey L., Moriarty, James P., Cartin-Ceba, Rodrigo, Berti, Alvise, Baqir, Misbah, Thompson, Gwen E., Makol, Ashima, Warrington, Kenneth J., Thao, Viengneesee, Specks, Ulrich, Fervenza, Fernando C.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Nephrology 2020
Assuntos:
Clinical Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7608964/
https://ncbi.nlm.nih.gov/pubmed/32826324
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2019111197
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados